ScinoPharm Taiwan Ltd (1789) — Cash Flow Quality Index
ScinoPharm Taiwan Ltd (1789) has a Cash Flow Quality Index of 12.07x as of March 2026. Operating cash flow of NT$199.47 Million exceeds net income of NT$16.53 Million, indicating high earnings quality where cash backs reported profits. Explore 1789 cash flow metrics to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
ScinoPharm Taiwan Ltd Cash Flow Quality Index (2007–2025)
Historical Cash Flow Quality Index for ScinoPharm Taiwan Ltd across 19 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check ScinoPharm Taiwan Ltd (1789) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for ScinoPharm Taiwan Ltd (2007–2025)
Year-by-year earnings quality comparison for ScinoPharm Taiwan Ltd. For live market cap and the full company financial profile, see market value of ScinoPharm Taiwan Ltd.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 4.36x | NT$597.11 Million | NT$136.95 Million | ▲ +139.8% |
| 2024 | 1.82x | NT$750.91 Million | NT$413.02 Million | ▲ +174.4% |
| 2023 | 0.66x | NT$231.13 Million | NT$348.84 Million | ▼ -62.5% |
| 2022 | 1.77x | NT$773.79 Million | NT$437.96 Million | ▲ +4.8% |
| 2021 | 1.69x | NT$509.82 Million | NT$302.29 Million | ▼ -36.1% |
| 2020 | 2.64x | NT$946.31 Million | NT$358.50 Million | ▼ -11.3% |
| 2019 | 2.98x | NT$788.95 Million | NT$265.05 Million | ▲ +18.6% |
| 2018 | 2.51x | NT$1.23 Billion | NT$490.54 Million | ▲ +22.8% |
| 2017 | 2.04x | NT$971.71 Million | NT$475.30 Million | ▼ -0.5% |
| 2016 | 2.05x | NT$1.67 Billion | NT$810.60 Million | ▲ +57.9% |
| 2015 | 1.30x | NT$1.04 Billion | NT$802.88 Million | ▼ -11.8% |
| 2014 | 1.48x | NT$888.29 Million | NT$602.21 Million | ▲ +121.1% |
| 2013 | 0.67x | NT$939.47 Million | NT$1.41 Billion | ▼ -6.8% |
| 2012 | 0.72x | NT$981.55 Million | NT$1.37 Billion | ▼ -46.9% |
| 2011 | 1.35x | NT$1.29 Billion | NT$961.32 Million | ▼ -10.5% |
| 2010 | 1.50x | NT$1.56 Billion | NT$1.04 Billion | ▲ +20.5% |
| 2009 | 1.25x | NT$1.30 Billion | NT$1.04 Billion | ▼ -22.6% |
| 2008 | 1.61x | NT$1.41 Billion | NT$872.11 Million | ▲ +96.2% |
| 2007 | 0.82x | NT$504.50 Million | NT$613.27 Million | — |